<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>OrthoSpineNews &#187; Biologics</title>
	<atom:link href="http://www.orthospinenews.com/category/biologics/feed" rel="self" type="application/rss+xml" />
	<link>http://www.orthospinenews.com</link>
	<description>The latest news for the orthopedic and spine industries</description>
	<lastBuildDate>Mon, 17 Jun 2013 15:46:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>MiMedx Is Issued Three New U.S. Patents For Placental Tissue Allografts</title>
		<link>http://www.orthospinenews.com/mimedx-is-issued-three-new-u-s-patents-for-placental-tissue-allografts</link>
		<comments>http://www.orthospinenews.com/mimedx-is-issued-three-new-u-s-patents-for-placental-tissue-allografts#comments</comments>
		<pubDate>Mon, 17 Jun 2013 15:43:03 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[allografts]]></category>
		<category><![CDATA[MiMedx]]></category>
		<category><![CDATA[patents]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=7185</guid>
		<description><![CDATA[MARIETTA, Ga., June 11, 2013 /PRNewswire/ &#8211; MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of three newly issued patents related to tissue allografts derived ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/mimedx-is-issued-three-new-u-s-patents-for-placental-tissue-allografts/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Israeli inventions underpin 20% of global biotech revenue</title>
		<link>http://www.orthospinenews.com/israeli-inventions-underpin-20-of-global-biotech-revenue</link>
		<comments>http://www.orthospinenews.com/israeli-inventions-underpin-20-of-global-biotech-revenue#comments</comments>
		<pubDate>Fri, 07 Jun 2013 22:28:18 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[israeli]]></category>
		<category><![CDATA[Product Launch]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=7158</guid>
		<description><![CDATA[Israel&#8217;s life sciences industry is manic-depressive. One moment, it&#8217;s preparing for catastrophe and pending collapse, and the next, it&#8217;s celebrating the industry&#8217;s hoped-for breakthrough. There is no argument that Israel&#8217;s science and medicine are outstanding, and there is the feeling ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/israeli-inventions-underpin-20-of-global-biotech-revenue/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SANUWAVE Appoints Daniel M. Jorgensen as Chief Medical Officer</title>
		<link>http://www.orthospinenews.com/sanuwave-appoints-daniel-m-jorgensen-as-chief-medical-officer</link>
		<comments>http://www.orthospinenews.com/sanuwave-appoints-daniel-m-jorgensen-as-chief-medical-officer#comments</comments>
		<pubDate>Thu, 02 May 2013 21:22:31 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Appointment]]></category>
		<category><![CDATA[hire]]></category>
		<category><![CDATA[sanuwave]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=7119</guid>
		<description><![CDATA[ALPHARETTA, Ga., May 1, 2013 (GLOBE NEWSWIRE) &#8212; SANUWAVE Health, Inc. (OTCBB:SNWV) today announced the Company has appointed Daniel M. Jorgensen, MD, MPH, MBA as its Chief Medical Officer. Dr. Jorgensen is an accomplished physician executive with more than 15 ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/sanuwave-appoints-daniel-m-jorgensen-as-chief-medical-officer/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ISTO assumes full control of Zimmer cartilage implant</title>
		<link>http://www.orthospinenews.com/isto-assumes-full-control-of-zimmer-cartilage-implant</link>
		<comments>http://www.orthospinenews.com/isto-assumes-full-control-of-zimmer-cartilage-implant#comments</comments>
		<pubDate>Tue, 30 Apr 2013 20:52:12 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[isto]]></category>
		<category><![CDATA[Zimmer]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=7104</guid>
		<description><![CDATA[ISTO Technologies Inc. announced an agreement with Zimmer Holdings Inc. giving ISTO full control of the DeNovo ET Engineered Tissue program, an engineered cartilage implant intended to repair cartilage defects in the knee. According to a company press release, under ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/isto-assumes-full-control-of-zimmer-cartilage-implant/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wright Medical Group Inc. completes acquisition of BioMimetic Therapeutics</title>
		<link>http://www.orthospinenews.com/wright-medical-group-inc-completes-acquisition-of-biomimetic-therapeutics</link>
		<comments>http://www.orthospinenews.com/wright-medical-group-inc-completes-acquisition-of-biomimetic-therapeutics#comments</comments>
		<pubDate>Fri, 15 Mar 2013 21:48:41 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[acquired]]></category>
		<category><![CDATA[biomimetic therapeutics]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[pictures]]></category>
		<category><![CDATA[wmt]]></category>
		<category><![CDATA[wright]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=7021</guid>
		<description><![CDATA[Wright Medical Group Inc. recently announced that it has completed its acquisition of BioMimetic Therapeutics Inc. According to a company release, the move will further accelerate growth opportunities in Wright’s Extremities business by combining BioMimetic’s biologics platform and pipeline with ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/wright-medical-group-inc-completes-acquisition-of-biomimetic-therapeutics/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Groundbreaking Discovery Of Cell Nucleus Structure Crucial To Understanding Diseases</title>
		<link>http://www.orthospinenews.com/groundbreaking-discovery-of-cell-nucleus-structure-crucial-to-understanding-diseases</link>
		<comments>http://www.orthospinenews.com/groundbreaking-discovery-of-cell-nucleus-structure-crucial-to-understanding-diseases#comments</comments>
		<pubDate>Wed, 13 Feb 2013 16:58:31 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[clinical research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6974</guid>
		<description><![CDATA[Genes relocated from their correct position in the nucleus cause them to malfunction and this may lead to the heart, blood vessels and muscles breaking down. This new discovery by A*STAR scientists may be the key to finding new cures ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/groundbreaking-discovery-of-cell-nucleus-structure-crucial-to-understanding-diseases/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Artimplant AB : New Head of Research and Development at Artimplant</title>
		<link>http://www.orthospinenews.com/artimplant-ab-new-head-of-research-and-development-at-artimplant</link>
		<comments>http://www.orthospinenews.com/artimplant-ab-new-head-of-research-and-development-at-artimplant#comments</comments>
		<pubDate>Tue, 21 Aug 2012 17:43:26 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[artimplant]]></category>
		<category><![CDATA[hire]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6862</guid>
		<description><![CDATA[Katrin GisselfÃ¤lt is stepping down as Head of Research and Development at Artimplant to take up a position at another company. Lars Peterson will take over as Head of Research and Development until a suitable permanent solution has been found. ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/artimplant-ab-new-head-of-research-and-development-at-artimplant/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Human Bone Grown From Stem Cells</title>
		<link>http://www.orthospinenews.com/human-bone-grown-from-stem-cells</link>
		<comments>http://www.orthospinenews.com/human-bone-grown-from-stem-cells#comments</comments>
		<pubDate>Thu, 21 Jun 2012 22:11:15 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[ryortho]]></category>
		<category><![CDATA[stem cells]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6810</guid>
		<description><![CDATA[Bilione W. Young • Mon, Jun 18th, 2012 Print This Article Scientists at the Israeli biotechnology company Bonus BioGroup Ltd. have grown human bone from stem cells. Using stem cells taken from fat, they grew two-inch-long sections of fully formed living human ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/human-bone-grown-from-stem-cells/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Osiris Receives Medicare Reimbursement Codes for Grafix(R)</title>
		<link>http://www.orthospinenews.com/osiris-receives-medicare-reimbursement-codes-for-grafixr</link>
		<comments>http://www.orthospinenews.com/osiris-receives-medicare-reimbursement-codes-for-grafixr#comments</comments>
		<pubDate>Tue, 29 May 2012 22:38:51 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[osiris]]></category>
		<category><![CDATA[Reimbursement]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6792</guid>
		<description><![CDATA[COLUMBIA, Md., May 29, 2012 (BUSINESS WIRE) &#8212; Osiris Therapeutics, Inc. OSIR +3.34% , the leading stem cell company focused on developing and commercializing products to treat medical conditions in inflammatory, cardiovascular, orthopedic, and wound healing markets, announced today that it has received ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/osiris-receives-medicare-reimbursement-codes-for-grafixr/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medtronic receives notification that U.S. Department Of Justice and U.S. Attorney’s office have closed their investigation of activities relating to Infuse® bone graft</title>
		<link>http://www.orthospinenews.com/medtronic-receives-notification-that-u-s-department-of-justice-and-u-s-attorneys-office-have-closed-their-investigation-of-activities-relating-to-infuse-bone-graft</link>
		<comments>http://www.orthospinenews.com/medtronic-receives-notification-that-u-s-department-of-justice-and-u-s-attorneys-office-have-closed-their-investigation-of-activities-relating-to-infuse-bone-graft#comments</comments>
		<pubDate>Mon, 21 May 2012 17:39:00 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[doj]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[infuse]]></category>
		<category><![CDATA[mdt]]></category>
		<category><![CDATA[medtronic]]></category>
		<category><![CDATA[pictures]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6783</guid>
		<description><![CDATA[MINNEAPOLIS – MAY 16, 2012 – Medtronic, Inc. (NYSE: MDT) today announced it has been notified by the U.S. Department of Justice (DOJ) and the Office of the United States Attorney for the District of Massachusetts that federal prosecutors have closed their investigation of Medtronic ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/medtronic-receives-notification-that-u-s-department-of-justice-and-u-s-attorneys-office-have-closed-their-investigation-of-activities-relating-to-infuse-bone-graft/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Surgical sealant technology from HyperBranch gets CE Mark</title>
		<link>http://www.orthospinenews.com/surgical-sealant-technology-from-hyperbranch-gets-ce-mark</link>
		<comments>http://www.orthospinenews.com/surgical-sealant-technology-from-hyperbranch-gets-ce-mark#comments</comments>
		<pubDate>Wed, 16 May 2012 16:16:34 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[CE Mark]]></category>
		<category><![CDATA[hyperbranch]]></category>
		<category><![CDATA[milestone]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6759</guid>
		<description><![CDATA[Wound and surgical sealant developerHyperBranch Medical Technology has received the CE Mark for an applicator that delivers its sealant used in cranial and spinal surgeries. The Adherus AutoSpray Dural Sealant delivers HyperBranch’s dural sealant to prevent leaks of cerebrospinal fluid after the surgical ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/surgical-sealant-technology-from-hyperbranch-gets-ce-mark/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Smith &amp; Nephew Biologics new Joint Venture with Essex Woodlands &#8211; An Interview with Mark Augusti</title>
		<link>http://www.orthospinenews.com/smith-nephew-biologics-new-joint-venture-with-essex-woodlands-an-interview-with-mark-augusti</link>
		<comments>http://www.orthospinenews.com/smith-nephew-biologics-new-joint-venture-with-essex-woodlands-an-interview-with-mark-augusti#comments</comments>
		<pubDate>Tue, 15 May 2012 16:09:41 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[bioventus]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[joint venture]]></category>
		<category><![CDATA[pictures]]></category>
		<category><![CDATA[snn]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6750</guid>
		<description><![CDATA[We recently heard the news about Smith &#38; Nephew selling 51% of their Biologics division to Essex Woodlands in a Joint Venture. We caught up with the new President and CEO of the new company and got his thoughts on ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/smith-nephew-biologics-new-joint-venture-with-essex-woodlands-an-interview-with-mark-augusti/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>BioRestorative (BRTX): Two Huge Markets, One Solid Business Model</title>
		<link>http://www.orthospinenews.com/biorestorative-brtx-two-huge-markets-one-solid-business-model</link>
		<comments>http://www.orthospinenews.com/biorestorative-brtx-two-huge-markets-one-solid-business-model#comments</comments>
		<pubDate>Tue, 15 May 2012 15:53:22 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[milestone]]></category>
		<category><![CDATA[Product Launch]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6736</guid>
		<description><![CDATA[BioRestorative Therapies Inc. (OTCQB: BRTX), an emerging leader in autologous adult stem cell treatments for the disc/spine, metabolic disorders, and obesity, operating alongside companies like Pluristem Therapeutics Inc. (NASDAQ: PSTI) and Neuralstem Inc. (AMEX: CUR), represents a unique opportunity for investors ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/biorestorative-brtx-two-huge-markets-one-solid-business-model/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regentis Biomaterials Announces $10 Million Raised in Latest Round of Funding</title>
		<link>http://www.orthospinenews.com/regentis-biomaterials-announces-10-million-raised-in-latest-round-of-funding</link>
		<comments>http://www.orthospinenews.com/regentis-biomaterials-announces-10-million-raised-in-latest-round-of-funding#comments</comments>
		<pubDate>Tue, 15 May 2012 15:50:32 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[raised]]></category>
		<category><![CDATA[regentis]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6732</guid>
		<description><![CDATA[OR AKIVA, Israel and PRINCETON, New Jersey, May 14, 2012 &#8211; /PRNewswire/ &#8211; Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced that it has raised $10 million in its latest round of funding from new investors Royal DSM through its ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/regentis-biomaterials-announces-10-million-raised-in-latest-round-of-funding/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash</title>
		<link>http://www.orthospinenews.com/kensey-nash-agrees-to-be-acquired-by-dsm-for-38-50-per-share-in-cash</link>
		<comments>http://www.orthospinenews.com/kensey-nash-agrees-to-be-acquired-by-dsm-for-38-50-per-share-in-cash#comments</comments>
		<pubDate>Thu, 03 May 2012 22:08:12 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[acquire]]></category>
		<category><![CDATA[acquired]]></category>
		<category><![CDATA[dsm]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[kensey nash]]></category>
		<category><![CDATA[pictures]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6703</guid>
		<description><![CDATA[DSM will commence all-cash tender offer in May Tender Offer expected to be completed by June 30, 2012 EXTON, Pa., May 3, 2012 /PRNewswire/ &#8211;  Kensey Nash Corporation (Nasdaq: KNSY), today announced that it has entered into a definitive agreement with Royal DSM ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/kensey-nash-agrees-to-be-acquired-by-dsm-for-38-50-per-share-in-cash/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
